Steven M. Paul
Director at Seaport Therapeutics; Director at Rapport Therapeutics; Director at Alnylam Pharmaceuticals. Based in Boston, Massachusetts.
- Rank
- 3875th of 14,644
- Companies held
- 3
- Largest holding
- SPTX, 54.4% of total
- Latest SEC filing
- Oct 22, 2026
What the $29.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Seaport Therapeutics SPTX Common Stock | Directly | 863,031 | $18.32 | $15.8M | 54.4% | Form 4, May 4, 2026 |
| Rapport Therapeutics RAPP Common Stock | Directly | 477,642 | $23.59 | $11.3M | 38.8% | Form 4, Oct 22, 2026 |
| Rapport Therapeutics RAPP Common Stock | Through Paul Capital Strategy III Fund LLC | 77,380 | $23.59 | $1.8M | 6.3% | Form 4, Oct 22, 2026 |
| Alnylam Pharmaceuticals ALNY Common Stock | Directly | 1,000 | $147.82 | $148K | 0.5% | Form 4, Apr 1, 2022 |
Share counts are the amounts Steven M. Paul reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3872 | Normand A. Boulanger Director, SS&C Technologies Holdings. Windsor, CT | $29.1M |
| 3873 | Tyler Sloat Chief Financial & Oper Officer, Freshworks. San Mateo, CA | $29.1M |
| 3874 | Alexandra W. Schiff Director, Palantir Technologies. Aventura, FL | $29.1M |
| 3875 | Steven M. Paul Director, Seaport Therapeutics. Boston, MA | $29.1M |
| 3876 | Jeffrey Jonathan Brown Chief Executive Officer, Ally Financial. Memphis, TN | $29.0M |
| 3877 | Dennis B. Story EVP, CFO & Treasurer, Manhattan Associates. Atlanta, GA | $29.0M |
| 3878 | Laszlo Kopits General Counsel, Datadog. New York, NY | $29.0M |
Other Seaport Therapeutics insiders
All SPTX insiders- Daphne Zohar$20.0MChief Executive Officer. #5187 overall
- Denice Torres$337KDirector. #12613 overall
Questions
How much stock does Steven M. Paul own?
Steven M. Paul holds $29,051,517 in listed stock based on SEC filings and current prices, mostly Seaport Therapeutics (SPTX). That ranks 3875th on the Stock Rich List.
Is this Steven M. Paul's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Steven M. Paul last buy or sell stock?
The most recent open-market trade on file is a purchase of 35,714 RAPP shares on Oct 22, 2026 at $27.28.